127 related articles for article (PubMed ID: 8255998)
1. Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice.
Honess DJ; Dennis IF; Bleehen NM
Radiother Oncol; 1993 Sep; 28(3):208-18. PubMed ID: 8255998
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline increases RIF-1 tumour pO2 in a manner compatible with its ability to increase relative tumour perfusion.
Honess DJ; Andrews MS; Ward R; Bleehen NM
Acta Oncol; 1995; 34(3):385-9. PubMed ID: 7779427
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of hydralazine on perfusion of KHT tumor, kidney and liver and on renal function in mice.
Honess DJ; Bleehen NM
Int J Radiat Oncol Biol Phys; 1992; 22(5):953-61. PubMed ID: 1555988
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo studies using BW12C: toxicity, haemoglobin modification and effects on the radiosensitivity of normal marrow and RIF-1 tumours in mice.
Honess DJ; Nethersell AB; Bleehen NM
Int J Radiat Biol; 1992 Jan; 61(1):83-94. PubMed ID: 1345934
[TBL] [Abstract][Full Text] [Related]
5. Effects of the radiosensitising agent nicotinamide on relative tissue perfusion and kidney function in C3H mice.
Honess DJ; Bleehen NM
Radiother Oncol; 1993 May; 27(2):140-8. PubMed ID: 8356224
[TBL] [Abstract][Full Text] [Related]
6. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline.
Lee I; Boucher Y; Demhartner TJ; Jain RK
Br J Cancer; 1994 Mar; 69(3):492-6. PubMed ID: 8123479
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity.
Bennewith KL; Durand RE
Br J Cancer; 2001 Nov; 85(10):1577-84. PubMed ID: 11720448
[TBL] [Abstract][Full Text] [Related]
8. BW12C: effects on tumour hypoxia, tumour thermosensitivity and relative tumour and normal tissue perfusion in C3H mice.
Honess DJ; Hu DE; Bleehen NM
Br J Cancer; 1991 Oct; 64(4):715-22. PubMed ID: 1911220
[TBL] [Abstract][Full Text] [Related]
9. Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.
Honess DJ; Bleehen NM
Br J Cancer; 1995 Jun; 71(6):1175-80. PubMed ID: 7779707
[TBL] [Abstract][Full Text] [Related]
10. Increase in tumor blood flow by pentoxifylline.
Song CW; Makepeace CM; Griffin RJ; Hasegawa T; Osborn JL; Choi IB; Nah BS
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):433-7. PubMed ID: 8005795
[TBL] [Abstract][Full Text] [Related]
11. Modification of tumour response by calcium antagonists in the SCVII/St tumour implanted at two different sites.
Wood PJ; Hirst DG
Int J Radiat Biol; 1989 Sep; 56(3):355-67. PubMed ID: 2570820
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline enhances tumor oxygenation and radiosensitivity in rat rhabdomyosarcomas during continuous hyperfractionated irradiation.
Zywietz F; Böhm L; Sagowski C; Kehrl W
Strahlenther Onkol; 2004 May; 180(5):306-14. PubMed ID: 15127161
[TBL] [Abstract][Full Text] [Related]
13. Effect of the manipulation of oxyhemoglobin status by BW12C on tumor thermosensitivity and on blood flow in tumor and normal tissues in mice.
Honess DJ; White RD; Nethersell AB; Bleehen NM
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1187-90. PubMed ID: 2715069
[TBL] [Abstract][Full Text] [Related]
14. The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts.
Guichard M; Lespinasse F; Trotter M; Durand R; Chaplin D
Radiother Oncol; 1991 Feb; 20(2):117-23. PubMed ID: 2031087
[TBL] [Abstract][Full Text] [Related]
15. Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.
Chaplin DJ; Trotter MJ; Skov KA; Horsman MR
Br J Cancer; 1990 Oct; 62(4):561-6. PubMed ID: 2145963
[TBL] [Abstract][Full Text] [Related]
16. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline.
Song CW; Hasegawa T; Kwon HC; Lyons JC; Levitt SH
Radiat Res; 1992 May; 130(2):205-10. PubMed ID: 1574576
[TBL] [Abstract][Full Text] [Related]
17. Regional perfusion and oxygenation of tumors upon methylxanthine derivative administration.
Kelleher DK; Thews O; Vaupel P
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):861-4. PubMed ID: 9845111
[TBL] [Abstract][Full Text] [Related]
18. The effects of pentoxifylline infusion on plasma 6-keto-prostaglandin F1 alpha and ex vivo endotoxin-induced tumour necrosis factor activity in horses.
Barton MH; Ferguson D; Davis PJ; Moore JN
J Vet Pharmacol Ther; 1997 Dec; 20(6):487-92. PubMed ID: 9430774
[TBL] [Abstract][Full Text] [Related]
19. Increases in tumor response by pentoxifylline alone or in combination with nicotinamide.
Lee I; Kim JH; Levitt SH; Song CW
Int J Radiat Oncol Biol Phys; 1992; 22(3):425-9. PubMed ID: 1531211
[TBL] [Abstract][Full Text] [Related]
20. Modification of tumour blood flow using the hypertensive agent, angiotensin II.
Tozer GM; Shaffi KM
Br J Cancer; 1993 May; 67(5):981-8. PubMed ID: 8494732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
